nodes	percent_of_prediction	percent_of_DWPC	metapath
Nilotinib—EPHA2—pulmonary artery—thoracic aortic aneurysm	0.0326	0.184	CbGeAlD
Nilotinib—MAPK8—artery—thoracic aortic aneurysm	0.0204	0.116	CbGeAlD
Nilotinib—TEK—artery—thoracic aortic aneurysm	0.0118	0.0666	CbGeAlD
Nilotinib—CDC42BPB—cardiac atrium—thoracic aortic aneurysm	0.00712	0.0402	CbGeAlD
Nilotinib—CDC42BPB—spinal cord—thoracic aortic aneurysm	0.00598	0.0338	CbGeAlD
Nilotinib—TIE1—cardiac atrium—thoracic aortic aneurysm	0.00558	0.0316	CbGeAlD
Nilotinib—MAPK8—spinal cord—thoracic aortic aneurysm	0.00541	0.0306	CbGeAlD
Nilotinib—EPHB3—spinal cord—thoracic aortic aneurysm	0.00446	0.0252	CbGeAlD
Nilotinib—EPHA4—cardiac atrium—thoracic aortic aneurysm	0.00443	0.0251	CbGeAlD
Nilotinib—CA3—cardiac atrium—thoracic aortic aneurysm	0.00438	0.0248	CbGeAlD
Nilotinib—HCK—spinal cord—thoracic aortic aneurysm	0.0041	0.0232	CbGeAlD
Nilotinib—CA14—cardiac atrium—thoracic aortic aneurysm	0.00398	0.0225	CbGeAlD
Nilotinib—EPHB4—cardiac atrium—thoracic aortic aneurysm	0.00388	0.0219	CbGeAlD
Nilotinib—EPHA2—cardiac atrium—thoracic aortic aneurysm	0.0038	0.0215	CbGeAlD
Nilotinib—TEK—cardiac atrium—thoracic aortic aneurysm	0.00371	0.021	CbGeAlD
Nilotinib—EPHB6—cardiac atrium—thoracic aortic aneurysm	0.00354	0.02	CbGeAlD
Nilotinib—MAPK14—spinal cord—thoracic aortic aneurysm	0.00344	0.0194	CbGeAlD
Nilotinib—CA14—spinal cord—thoracic aortic aneurysm	0.00334	0.0189	CbGeAlD
Nilotinib—EPHB4—spinal cord—thoracic aortic aneurysm	0.00326	0.0184	CbGeAlD
Nilotinib—TEK—spinal cord—thoracic aortic aneurysm	0.00312	0.0176	CbGeAlD
Nilotinib—MAP2K5—cardiac atrium—thoracic aortic aneurysm	0.00303	0.0171	CbGeAlD
Nilotinib—EPHB6—spinal cord—thoracic aortic aneurysm	0.00298	0.0168	CbGeAlD
Nilotinib—CSF1R—cardiac atrium—thoracic aortic aneurysm	0.00296	0.0167	CbGeAlD
Nilotinib—PDGFRA—spinal cord—thoracic aortic aneurysm	0.00282	0.016	CbGeAlD
Nilotinib—PDGFRB—cardiac atrium—thoracic aortic aneurysm	0.00262	0.0148	CbGeAlD
Nilotinib—MAP2K5—spinal cord—thoracic aortic aneurysm	0.00255	0.0144	CbGeAlD
Nilotinib—CSF1R—spinal cord—thoracic aortic aneurysm	0.00249	0.0141	CbGeAlD
Nilotinib—ABL1—cardiac atrium—thoracic aortic aneurysm	0.00234	0.0132	CbGeAlD
Nilotinib—KIT—spinal cord—thoracic aortic aneurysm	0.00226	0.0128	CbGeAlD
Nilotinib—PDGFRB—spinal cord—thoracic aortic aneurysm	0.00221	0.0125	CbGeAlD
Nilotinib—CA1—spinal cord—thoracic aortic aneurysm	0.00207	0.0117	CbGeAlD
Nilotinib—ABL1—spinal cord—thoracic aortic aneurysm	0.00197	0.0111	CbGeAlD
Nilotinib—CA4—cardiac atrium—thoracic aortic aneurysm	0.00192	0.0109	CbGeAlD
Nilotinib—CA4—spinal cord—thoracic aortic aneurysm	0.00161	0.00913	CbGeAlD
Nilotinib—CA2—cardiac atrium—thoracic aortic aneurysm	0.00159	0.009	CbGeAlD
Nilotinib—CA2—spinal cord—thoracic aortic aneurysm	0.00134	0.00757	CbGeAlD
Nilotinib—ABCG2—spinal cord—thoracic aortic aneurysm	0.00124	0.00701	CbGeAlD
Nilotinib—LCK—Signaling by EGFR—ADAM17—thoracic aortic aneurysm	0.000701	0.000851	CbGpPWpGaD
Nilotinib—LCK—Signaling by EGFR in Cancer—ADAM17—thoracic aortic aneurysm	0.000694	0.000844	CbGpPWpGaD
Nilotinib—LYN—Platelet activation, signaling and aggregation—TGFB2—thoracic aortic aneurysm	0.000692	0.000841	CbGpPWpGaD
Nilotinib—EPHA6—Developmental Biology—ADAM10—thoracic aortic aneurysm	0.000691	0.00084	CbGpPWpGaD
Nilotinib—ABL1—Integrated Breast Cancer Pathway—TGFBR2—thoracic aortic aneurysm	0.000691	0.00084	CbGpPWpGaD
Nilotinib—MAPK14—FGF signaling pathway—MMP9—thoracic aortic aneurysm	0.000681	0.000828	CbGpPWpGaD
Nilotinib—EPHA3—Developmental Biology—SMAD3—thoracic aortic aneurysm	0.000671	0.000815	CbGpPWpGaD
Nilotinib—ABL2—Developmental Biology—SMAD3—thoracic aortic aneurysm	0.000671	0.000815	CbGpPWpGaD
Nilotinib—PDGFRB—Signaling by EGFR—ADAM10—thoracic aortic aneurysm	0.000669	0.000813	CbGpPWpGaD
Nilotinib—UGT1A1—NRF2 pathway—TGFBR2—thoracic aortic aneurysm	0.000668	0.000811	CbGpPWpGaD
Nilotinib—PDGFRA—Signaling by NGF—ADAM17—thoracic aortic aneurysm	0.000666	0.000809	CbGpPWpGaD
Nilotinib—PDGFRB—Signaling by EGFR in Cancer—ADAM10—thoracic aortic aneurysm	0.000663	0.000806	CbGpPWpGaD
Nilotinib—LYN—Developmental Biology—MYH11—thoracic aortic aneurysm	0.000661	0.000803	CbGpPWpGaD
Nilotinib—ABL1—Developmental Biology—MYH11—thoracic aortic aneurysm	0.000658	0.000799	CbGpPWpGaD
Nilotinib—MAPK14—Platelet activation, signaling and aggregation—TGFB2—thoracic aortic aneurysm	0.000656	0.000797	CbGpPWpGaD
Nilotinib—PDGFRB—MAPK Signaling Pathway—TGFBR2—thoracic aortic aneurysm	0.000651	0.000791	CbGpPWpGaD
Nilotinib—MAPK14—TGF-beta Signaling Pathway—SMAD3—thoracic aortic aneurysm	0.000649	0.000788	CbGpPWpGaD
Nilotinib—EPHA8—Developmental Biology—SMAD3—thoracic aortic aneurysm	0.000647	0.000786	CbGpPWpGaD
Nilotinib—BLK—Adaptive Immune System—PRKG1—thoracic aortic aneurysm	0.000647	0.000786	CbGpPWpGaD
Nilotinib—EPHA3—Axon guidance—MMP2—thoracic aortic aneurysm	0.000643	0.000781	CbGpPWpGaD
Nilotinib—ABL2—Axon guidance—MMP2—thoracic aortic aneurysm	0.000643	0.000781	CbGpPWpGaD
Nilotinib—EPHA4—Developmental Biology—SMAD3—thoracic aortic aneurysm	0.00064	0.000778	CbGpPWpGaD
Nilotinib—EPHB4—Developmental Biology—SMAD3—thoracic aortic aneurysm	0.00064	0.000778	CbGpPWpGaD
Nilotinib—EPHA2—Developmental Biology—ADAM10—thoracic aortic aneurysm	0.000638	0.000775	CbGpPWpGaD
Nilotinib—LYN—LPA receptor mediated events—MMP9—thoracic aortic aneurysm	0.000627	0.000762	CbGpPWpGaD
Nilotinib—MAPK14—Developmental Biology—MYH11—thoracic aortic aneurysm	0.000626	0.000761	CbGpPWpGaD
Nilotinib—EPHA8—Axon guidance—MMP2—thoracic aortic aneurysm	0.00062	0.000753	CbGpPWpGaD
Nilotinib—EPHB2—Developmental Biology—SMAD3—thoracic aortic aneurysm	0.00062	0.000753	CbGpPWpGaD
Nilotinib—LYN—EPH-Ephrin signaling—MMP2—thoracic aortic aneurysm	0.000614	0.000745	CbGpPWpGaD
Nilotinib—EPHB4—Axon guidance—MMP2—thoracic aortic aneurysm	0.000613	0.000745	CbGpPWpGaD
Nilotinib—EPHA4—Axon guidance—MMP2—thoracic aortic aneurysm	0.000613	0.000745	CbGpPWpGaD
Nilotinib—ABCB1—spinal cord—thoracic aortic aneurysm	0.000611	0.00346	CbGeAlD
Nilotinib—MAPK14—MAPK Signaling Pathway—TGFBR2—thoracic aortic aneurysm	0.000605	0.000734	CbGpPWpGaD
Nilotinib—EPHB6—Developmental Biology—SMAD3—thoracic aortic aneurysm	0.000602	0.000731	CbGpPWpGaD
Nilotinib—PDGFRB—Signaling by NGF—ADAM17—thoracic aortic aneurysm	0.0006	0.000729	CbGpPWpGaD
Nilotinib—LYN—Cytokine Signaling in Immune system—ADAM17—thoracic aortic aneurysm	0.000598	0.000726	CbGpPWpGaD
Nilotinib—EPHB2—Axon guidance—MMP2—thoracic aortic aneurysm	0.000594	0.000721	CbGpPWpGaD
Nilotinib—FGR—Hemostasis—TGFB2—thoracic aortic aneurysm	0.000593	0.00072	CbGpPWpGaD
Nilotinib—MAPK14—AGE/RAGE pathway—MMP9—thoracic aortic aneurysm	0.00058	0.000705	CbGpPWpGaD
Nilotinib—EPHB6—Axon guidance—MMP2—thoracic aortic aneurysm	0.000576	0.0007	CbGpPWpGaD
Nilotinib—LCK—Platelet activation, signaling and aggregation—TGFB2—thoracic aortic aneurysm	0.000567	0.000689	CbGpPWpGaD
Nilotinib—EPHA6—Developmental Biology—SMAD3—thoracic aortic aneurysm	0.000566	0.000687	CbGpPWpGaD
Nilotinib—MAPK14—Signaling by NGF—ADAM17—thoracic aortic aneurysm	0.000557	0.000677	CbGpPWpGaD
Nilotinib—EPHA6—Axon guidance—MMP2—thoracic aortic aneurysm	0.000542	0.000658	CbGpPWpGaD
Nilotinib—EPHB3—Axon guidance—MMP9—thoracic aortic aneurysm	0.000542	0.000658	CbGpPWpGaD
Nilotinib—LCK—Signaling by EGFR—ADAM10—thoracic aortic aneurysm	0.000537	0.000652	CbGpPWpGaD
Nilotinib—LCK—Signaling by EGFR in Cancer—ADAM10—thoracic aortic aneurysm	0.000532	0.000647	CbGpPWpGaD
Nilotinib—EPHA2—Developmental Biology—SMAD3—thoracic aortic aneurysm	0.000522	0.000634	CbGpPWpGaD
Nilotinib—EPHB3—Developmental Biology—MMP2—thoracic aortic aneurysm	0.000515	0.000625	CbGpPWpGaD
Nilotinib—ABCB1—HIF-1-alpha transcription factor network—SMAD3—thoracic aortic aneurysm	0.000511	0.000621	CbGpPWpGaD
Nilotinib—LYN—CXCR4-mediated signaling events—MMP9—thoracic aortic aneurysm	0.000505	0.000613	CbGpPWpGaD
Nilotinib—EPHA2—Axon guidance—MMP2—thoracic aortic aneurysm	0.0005	0.000607	CbGpPWpGaD
Nilotinib—LCK—Cytokine Signaling in Immune system—ADAM17—thoracic aortic aneurysm	0.00049	0.000595	CbGpPWpGaD
Nilotinib—ABL2—Axon guidance—MMP9—thoracic aortic aneurysm	0.000483	0.000587	CbGpPWpGaD
Nilotinib—EPHA3—Axon guidance—MMP9—thoracic aortic aneurysm	0.000483	0.000587	CbGpPWpGaD
Nilotinib—LCK—Signaling by NGF—ADAM17—thoracic aortic aneurysm	0.000482	0.000585	CbGpPWpGaD
Nilotinib—EPHA8—Axon guidance—MMP9—thoracic aortic aneurysm	0.000466	0.000566	CbGpPWpGaD
Nilotinib—KIT—Adaptive Immune System—PRKG1—thoracic aortic aneurysm	0.000465	0.000565	CbGpPWpGaD
Nilotinib—LYN—EPH-Ephrin signaling—MMP9—thoracic aortic aneurysm	0.000461	0.00056	CbGpPWpGaD
Nilotinib—EPHA4—Axon guidance—MMP9—thoracic aortic aneurysm	0.000461	0.00056	CbGpPWpGaD
Nilotinib—EPHB4—Axon guidance—MMP9—thoracic aortic aneurysm	0.000461	0.00056	CbGpPWpGaD
Nilotinib—EPHA3—Developmental Biology—MMP2—thoracic aortic aneurysm	0.000459	0.000557	CbGpPWpGaD
Nilotinib—ABL2—Developmental Biology—MMP2—thoracic aortic aneurysm	0.000459	0.000557	CbGpPWpGaD
Nilotinib—LYN—Hemostasis—PRKG1—thoracic aortic aneurysm	0.000449	0.000546	CbGpPWpGaD
Nilotinib—ABL1—Hemostasis—PRKG1—thoracic aortic aneurysm	0.000447	0.000543	CbGpPWpGaD
Nilotinib—EPHB2—Axon guidance—MMP9—thoracic aortic aneurysm	0.000446	0.000542	CbGpPWpGaD
Nilotinib—EPHA8—Developmental Biology—MMP2—thoracic aortic aneurysm	0.000443	0.000538	CbGpPWpGaD
Nilotinib—PDGFRA—Adaptive Immune System—PRKG1—thoracic aortic aneurysm	0.00044	0.000535	CbGpPWpGaD
Nilotinib—EPHA4—Developmental Biology—MMP2—thoracic aortic aneurysm	0.000438	0.000532	CbGpPWpGaD
Nilotinib—EPHB4—Developmental Biology—MMP2—thoracic aortic aneurysm	0.000438	0.000532	CbGpPWpGaD
Nilotinib—HCK—Immune System—PRKG1—thoracic aortic aneurysm	0.000433	0.000526	CbGpPWpGaD
Nilotinib—EPHB6—Axon guidance—MMP9—thoracic aortic aneurysm	0.000433	0.000526	CbGpPWpGaD
Nilotinib—MAPK14—Hemostasis—PRKG1—thoracic aortic aneurysm	0.000426	0.000517	CbGpPWpGaD
Nilotinib—EPHB2—Developmental Biology—MMP2—thoracic aortic aneurysm	0.000424	0.000515	CbGpPWpGaD
Nilotinib—LCK—CXCR4-mediated signaling events—MMP9—thoracic aortic aneurysm	0.000414	0.000502	CbGpPWpGaD
Nilotinib—EPHB6—Developmental Biology—MMP2—thoracic aortic aneurysm	0.000411	0.0005	CbGpPWpGaD
Nilotinib—LYN—Axon guidance—ADAM10—thoracic aortic aneurysm	0.000408	0.000495	CbGpPWpGaD
Nilotinib—EPHA6—Axon guidance—MMP9—thoracic aortic aneurysm	0.000407	0.000495	CbGpPWpGaD
Nilotinib—ABL1—Axon guidance—ADAM10—thoracic aortic aneurysm	0.000406	0.000493	CbGpPWpGaD
Nilotinib—KIT—Signaling by SCF-KIT—MMP9—thoracic aortic aneurysm	0.000399	0.000485	CbGpPWpGaD
Nilotinib—PDGFRB—Adaptive Immune System—PRKG1—thoracic aortic aneurysm	0.000397	0.000482	CbGpPWpGaD
Nilotinib—MAPK8—Immune System—PRKG1—thoracic aortic aneurysm	0.000393	0.000477	CbGpPWpGaD
Nilotinib—BLK—Immune System—PRKG1—thoracic aortic aneurysm	0.000393	0.000477	CbGpPWpGaD
Nilotinib—FGR—Immune System—PRKG1—thoracic aortic aneurysm	0.000391	0.000475	CbGpPWpGaD
Nilotinib—LYN—Adaptive Immune System—PRKG1—thoracic aortic aneurysm	0.000388	0.000472	CbGpPWpGaD
Nilotinib—EPHA6—Developmental Biology—MMP2—thoracic aortic aneurysm	0.000387	0.00047	CbGpPWpGaD
Nilotinib—EPHB3—Developmental Biology—MMP9—thoracic aortic aneurysm	0.000387	0.00047	CbGpPWpGaD
Nilotinib—MAPK11—Developmental Biology—ADAM10—thoracic aortic aneurysm	0.000386	0.000469	CbGpPWpGaD
Nilotinib—PDGFRA—Signaling by SCF-KIT—MMP9—thoracic aortic aneurysm	0.000378	0.000459	CbGpPWpGaD
Nilotinib—EPHA2—Axon guidance—MMP9—thoracic aortic aneurysm	0.000376	0.000456	CbGpPWpGaD
Nilotinib—LCK—Hemostasis—PRKG1—thoracic aortic aneurysm	0.000368	0.000447	CbGpPWpGaD
Nilotinib—HCK—Immune System—ADAM17—thoracic aortic aneurysm	0.000359	0.000436	CbGpPWpGaD
Nilotinib—LYN—Hemostasis—TGFB2—thoracic aortic aneurysm	0.000357	0.000434	CbGpPWpGaD
Nilotinib—EPHA2—Developmental Biology—MMP2—thoracic aortic aneurysm	0.000357	0.000433	CbGpPWpGaD
Nilotinib—ABL1—Hemostasis—TGFB2—thoracic aortic aneurysm	0.000355	0.000432	CbGpPWpGaD
Nilotinib—ABCB1—Integrated Pancreatic Cancer Pathway—TGFBR1—thoracic aortic aneurysm	0.000348	0.000423	CbGpPWpGaD
Nilotinib—ABL2—Developmental Biology—MMP9—thoracic aortic aneurysm	0.000345	0.000419	CbGpPWpGaD
Nilotinib—EPHA3—Developmental Biology—MMP9—thoracic aortic aneurysm	0.000345	0.000419	CbGpPWpGaD
Nilotinib—PDGFRB—Signaling by SCF-KIT—MMP9—thoracic aortic aneurysm	0.000341	0.000414	CbGpPWpGaD
Nilotinib—MAPK14—Hemostasis—TGFB2—thoracic aortic aneurysm	0.000338	0.000411	CbGpPWpGaD
Nilotinib—LYN—Signaling by SCF-KIT—MMP9—thoracic aortic aneurysm	0.000333	0.000405	CbGpPWpGaD
Nilotinib—EPHA8—Developmental Biology—MMP9—thoracic aortic aneurysm	0.000333	0.000404	CbGpPWpGaD
Nilotinib—HCK—Disease—TGFBR1—thoracic aortic aneurysm	0.000332	0.000403	CbGpPWpGaD
Nilotinib—HCK—Disease—ADAM17—thoracic aortic aneurysm	0.000332	0.000403	CbGpPWpGaD
Nilotinib—EPHA4—Developmental Biology—MMP9—thoracic aortic aneurysm	0.000329	0.0004	CbGpPWpGaD
Nilotinib—EPHB4—Developmental Biology—MMP9—thoracic aortic aneurysm	0.000329	0.0004	CbGpPWpGaD
Nilotinib—BLK—Immune System—ADAM17—thoracic aortic aneurysm	0.000325	0.000395	CbGpPWpGaD
Nilotinib—MAPK8—Immune System—ADAM17—thoracic aortic aneurysm	0.000325	0.000395	CbGpPWpGaD
Nilotinib—FGR—Immune System—ADAM17—thoracic aortic aneurysm	0.000324	0.000394	CbGpPWpGaD
Nilotinib—EPHB2—Developmental Biology—MMP9—thoracic aortic aneurysm	0.000319	0.000387	CbGpPWpGaD
Nilotinib—LCK—Adaptive Immune System—PRKG1—thoracic aortic aneurysm	0.000318	0.000387	CbGpPWpGaD
Nilotinib—MAPK11—Developmental Biology—SMAD3—thoracic aortic aneurysm	0.000316	0.000384	CbGpPWpGaD
Nilotinib—MAPK11—Immune System—PRKG1—thoracic aortic aneurysm	0.000313	0.00038	CbGpPWpGaD
Nilotinib—EPHB6—Developmental Biology—MMP9—thoracic aortic aneurysm	0.000309	0.000376	CbGpPWpGaD
Nilotinib—LCK—Hemostasis—TGFB2—thoracic aortic aneurysm	0.000292	0.000355	CbGpPWpGaD
Nilotinib—LYN—Developmental Biology—ADAM10—thoracic aortic aneurysm	0.000291	0.000353	CbGpPWpGaD
Nilotinib—EPHA6—Developmental Biology—MMP9—thoracic aortic aneurysm	0.000291	0.000353	CbGpPWpGaD
Nilotinib—ABL1—Developmental Biology—ADAM10—thoracic aortic aneurysm	0.000289	0.000352	CbGpPWpGaD
Nilotinib—KIT—Immune System—PRKG1—thoracic aortic aneurysm	0.000282	0.000343	CbGpPWpGaD
Nilotinib—MAPK14—Developmental Biology—ADAM10—thoracic aortic aneurysm	0.000276	0.000335	CbGpPWpGaD
Nilotinib—LCK—Signaling by SCF-KIT—MMP9—thoracic aortic aneurysm	0.000273	0.000332	CbGpPWpGaD
Nilotinib—EPHA2—Developmental Biology—MMP9—thoracic aortic aneurysm	0.000268	0.000326	CbGpPWpGaD
Nilotinib—PDGFRA—Immune System—PRKG1—thoracic aortic aneurysm	0.000267	0.000324	CbGpPWpGaD
Nilotinib—MAPK11—Immune System—ADAM17—thoracic aortic aneurysm	0.000259	0.000315	CbGpPWpGaD
Nilotinib—HCK—Disease—ADAM10—thoracic aortic aneurysm	0.000254	0.000309	CbGpPWpGaD
Nilotinib—MAPK8—Signaling Pathways—PRKG1—thoracic aortic aneurysm	0.000254	0.000308	CbGpPWpGaD
Nilotinib—MAP2K5—Signaling Pathways—PRKG1—thoracic aortic aneurysm	0.000241	0.000293	CbGpPWpGaD
Nilotinib—PDGFRB—Immune System—PRKG1—thoracic aortic aneurysm	0.000241	0.000292	CbGpPWpGaD
Nilotinib—LYN—Developmental Biology—SMAD3—thoracic aortic aneurysm	0.000238	0.000289	CbGpPWpGaD
Nilotinib—BRAF—Disease—ADAM17—thoracic aortic aneurysm	0.000237	0.000288	CbGpPWpGaD
Nilotinib—BRAF—Disease—TGFBR1—thoracic aortic aneurysm	0.000237	0.000288	CbGpPWpGaD
Nilotinib—ABL1—Developmental Biology—SMAD3—thoracic aortic aneurysm	0.000237	0.000288	CbGpPWpGaD
Nilotinib—LYN—Immune System—PRKG1—thoracic aortic aneurysm	0.000236	0.000286	CbGpPWpGaD
Nilotinib—HCK—Disease—TGFBR2—thoracic aortic aneurysm	0.000235	0.000286	CbGpPWpGaD
Nilotinib—ABL1—Immune System—PRKG1—thoracic aortic aneurysm	0.000234	0.000285	CbGpPWpGaD
Nilotinib—KIT—Immune System—ADAM17—thoracic aortic aneurysm	0.000234	0.000284	CbGpPWpGaD
Nilotinib—LYN—Axon guidance—MMP2—thoracic aortic aneurysm	0.000228	0.000277	CbGpPWpGaD
Nilotinib—ABL1—Axon guidance—MMP2—thoracic aortic aneurysm	0.000227	0.000276	CbGpPWpGaD
Nilotinib—MAPK14—Developmental Biology—SMAD3—thoracic aortic aneurysm	0.000226	0.000274	CbGpPWpGaD
Nilotinib—MAPK14—Immune System—PRKG1—thoracic aortic aneurysm	0.000223	0.000271	CbGpPWpGaD
Nilotinib—PDGFRA—Immune System—ADAM17—thoracic aortic aneurysm	0.000221	0.000269	CbGpPWpGaD
Nilotinib—MAPK11—Developmental Biology—MMP2—thoracic aortic aneurysm	0.000216	0.000263	CbGpPWpGaD
Nilotinib—KIT—Disease—ADAM17—thoracic aortic aneurysm	0.000216	0.000262	CbGpPWpGaD
Nilotinib—KIT—Disease—TGFBR1—thoracic aortic aneurysm	0.000216	0.000262	CbGpPWpGaD
Nilotinib—MAPK8—Signaling Pathways—ADAM17—thoracic aortic aneurysm	0.00021	0.000256	CbGpPWpGaD
Nilotinib—MAPK8—Signaling Pathways—TGFBR1—thoracic aortic aneurysm	0.00021	0.000256	CbGpPWpGaD
Nilotinib—HCK—Disease—SMAD3—thoracic aortic aneurysm	0.000208	0.000253	CbGpPWpGaD
Nilotinib—PDGFRA—Disease—ADAM17—thoracic aortic aneurysm	0.000204	0.000248	CbGpPWpGaD
Nilotinib—PDGFRA—Disease—TGFBR1—thoracic aortic aneurysm	0.000204	0.000248	CbGpPWpGaD
Nilotinib—MAPK11—Signaling Pathways—PRKG1—thoracic aortic aneurysm	0.000202	0.000246	CbGpPWpGaD
Nilotinib—BRAF—Signaling Pathways—PRKG1—thoracic aortic aneurysm	0.0002	0.000243	CbGpPWpGaD
Nilotinib—MAP2K5—Signaling Pathways—ADAM17—thoracic aortic aneurysm	0.0002	0.000243	CbGpPWpGaD
Nilotinib—MAP2K5—Signaling Pathways—TGFBR1—thoracic aortic aneurysm	0.0002	0.000243	CbGpPWpGaD
Nilotinib—PDGFRB—Immune System—ADAM17—thoracic aortic aneurysm	0.000199	0.000242	CbGpPWpGaD
Nilotinib—LYN—Immune System—ADAM17—thoracic aortic aneurysm	0.000195	0.000237	CbGpPWpGaD
Nilotinib—ABL1—Immune System—ADAM17—thoracic aortic aneurysm	0.000194	0.000236	CbGpPWpGaD
Nilotinib—LCK—Immune System—PRKG1—thoracic aortic aneurysm	0.000193	0.000235	CbGpPWpGaD
Nilotinib—MAPK14—Immune System—ADAM17—thoracic aortic aneurysm	0.000185	0.000225	CbGpPWpGaD
Nilotinib—PDGFRB—Disease—ADAM17—thoracic aortic aneurysm	0.000184	0.000224	CbGpPWpGaD
Nilotinib—PDGFRB—Disease—TGFBR1—thoracic aortic aneurysm	0.000184	0.000224	CbGpPWpGaD
Nilotinib—KIT—Signaling Pathways—PRKG1—thoracic aortic aneurysm	0.000182	0.000222	CbGpPWpGaD
Nilotinib—BRAF—Disease—ADAM10—thoracic aortic aneurysm	0.000182	0.000221	CbGpPWpGaD
Nilotinib—PDGFRA—Signaling Pathways—PRKG1—thoracic aortic aneurysm	0.000173	0.00021	CbGpPWpGaD
Nilotinib—LYN—Axon guidance—MMP9—thoracic aortic aneurysm	0.000171	0.000208	CbGpPWpGaD
Nilotinib—ABL1—Axon guidance—MMP9—thoracic aortic aneurysm	0.000171	0.000207	CbGpPWpGaD
Nilotinib—BRAF—Disease—TGFBR2—thoracic aortic aneurysm	0.000168	0.000204	CbGpPWpGaD
Nilotinib—MAPK11—Signaling Pathways—ADAM17—thoracic aortic aneurysm	0.000168	0.000204	CbGpPWpGaD
Nilotinib—MAPK11—Signaling Pathways—TGFBR1—thoracic aortic aneurysm	0.000168	0.000204	CbGpPWpGaD
Nilotinib—BRAF—Signaling Pathways—ADAM17—thoracic aortic aneurysm	0.000166	0.000202	CbGpPWpGaD
Nilotinib—BRAF—Signaling Pathways—TGFBR1—thoracic aortic aneurysm	0.000166	0.000202	CbGpPWpGaD
Nilotinib—KIT—Disease—ADAM10—thoracic aortic aneurysm	0.000165	0.000201	CbGpPWpGaD
Nilotinib—LYN—Developmental Biology—MMP2—thoracic aortic aneurysm	0.000163	0.000198	CbGpPWpGaD
Nilotinib—MAPK11—Developmental Biology—MMP9—thoracic aortic aneurysm	0.000162	0.000197	CbGpPWpGaD
Nilotinib—ABL1—Developmental Biology—MMP2—thoracic aortic aneurysm	0.000162	0.000197	CbGpPWpGaD
Nilotinib—MAPK11—Gene Expression—SMAD3—thoracic aortic aneurysm	0.000162	0.000196	CbGpPWpGaD
Nilotinib—MAPK8—Signaling Pathways—ADAM10—thoracic aortic aneurysm	0.000161	0.000196	CbGpPWpGaD
Nilotinib—LCK—Immune System—ADAM17—thoracic aortic aneurysm	0.00016	0.000194	CbGpPWpGaD
Nilotinib—PDGFRA—Disease—ADAM10—thoracic aortic aneurysm	0.000157	0.00019	CbGpPWpGaD
Nilotinib—PDGFRB—Signaling Pathways—PRKG1—thoracic aortic aneurysm	0.000156	0.000189	CbGpPWpGaD
Nilotinib—MAPK14—Developmental Biology—MMP2—thoracic aortic aneurysm	0.000154	0.000187	CbGpPWpGaD
Nilotinib—MAP2K5—Signaling Pathways—ADAM10—thoracic aortic aneurysm	0.000153	0.000186	CbGpPWpGaD
Nilotinib—KIT—Disease—TGFBR2—thoracic aortic aneurysm	0.000153	0.000186	CbGpPWpGaD
Nilotinib—LYN—Signaling Pathways—PRKG1—thoracic aortic aneurysm	0.000152	0.000185	CbGpPWpGaD
Nilotinib—KIT—Signaling Pathways—TGFBR1—thoracic aortic aneurysm	0.000151	0.000184	CbGpPWpGaD
Nilotinib—KIT—Signaling Pathways—ADAM17—thoracic aortic aneurysm	0.000151	0.000184	CbGpPWpGaD
Nilotinib—MAPK8—Signaling Pathways—TGFBR2—thoracic aortic aneurysm	0.000149	0.000181	CbGpPWpGaD
Nilotinib—BRAF—Disease—SMAD3—thoracic aortic aneurysm	0.000149	0.000181	CbGpPWpGaD
Nilotinib—LCK—Disease—ADAM17—thoracic aortic aneurysm	0.000148	0.000179	CbGpPWpGaD
Nilotinib—LCK—Disease—TGFBR1—thoracic aortic aneurysm	0.000148	0.000179	CbGpPWpGaD
Nilotinib—PDGFRA—Disease—TGFBR2—thoracic aortic aneurysm	0.000145	0.000176	CbGpPWpGaD
Nilotinib—MAPK14—Signaling Pathways—PRKG1—thoracic aortic aneurysm	0.000144	0.000175	CbGpPWpGaD
Nilotinib—PDGFRA—Signaling Pathways—ADAM17—thoracic aortic aneurysm	0.000143	0.000174	CbGpPWpGaD
Nilotinib—PDGFRA—Signaling Pathways—TGFBR1—thoracic aortic aneurysm	0.000143	0.000174	CbGpPWpGaD
Nilotinib—MAP2K5—Signaling Pathways—TGFBR2—thoracic aortic aneurysm	0.000142	0.000172	CbGpPWpGaD
Nilotinib—PDGFRB—Disease—ADAM10—thoracic aortic aneurysm	0.000141	0.000171	CbGpPWpGaD
Nilotinib—KIT—Disease—SMAD3—thoracic aortic aneurysm	0.000135	0.000164	CbGpPWpGaD
Nilotinib—MAPK8—Signaling Pathways—SMAD3—thoracic aortic aneurysm	0.000132	0.00016	CbGpPWpGaD
Nilotinib—PDGFRB—Disease—TGFBR2—thoracic aortic aneurysm	0.000131	0.000159	CbGpPWpGaD
Nilotinib—PDGFRB—Signaling Pathways—ADAM17—thoracic aortic aneurysm	0.000129	0.000157	CbGpPWpGaD
Nilotinib—PDGFRB—Signaling Pathways—TGFBR1—thoracic aortic aneurysm	0.000129	0.000157	CbGpPWpGaD
Nilotinib—MAPK11—Signaling Pathways—ADAM10—thoracic aortic aneurysm	0.000128	0.000156	CbGpPWpGaD
Nilotinib—PDGFRA—Disease—SMAD3—thoracic aortic aneurysm	0.000128	0.000156	CbGpPWpGaD
Nilotinib—BRAF—Signaling Pathways—ADAM10—thoracic aortic aneurysm	0.000127	0.000155	CbGpPWpGaD
Nilotinib—LYN—Signaling Pathways—ADAM17—thoracic aortic aneurysm	0.000126	0.000153	CbGpPWpGaD
Nilotinib—LYN—Signaling Pathways—TGFBR1—thoracic aortic aneurysm	0.000126	0.000153	CbGpPWpGaD
Nilotinib—MAP2K5—Signaling Pathways—SMAD3—thoracic aortic aneurysm	0.000125	0.000152	CbGpPWpGaD
Nilotinib—LCK—Signaling Pathways—PRKG1—thoracic aortic aneurysm	0.000125	0.000152	CbGpPWpGaD
Nilotinib—LYN—Developmental Biology—MMP9—thoracic aortic aneurysm	0.000122	0.000149	CbGpPWpGaD
Nilotinib—ABL1—Developmental Biology—MMP9—thoracic aortic aneurysm	0.000122	0.000148	CbGpPWpGaD
Nilotinib—MAPK14—Signaling Pathways—ADAM17—thoracic aortic aneurysm	0.00012	0.000145	CbGpPWpGaD
Nilotinib—MAPK14—Signaling Pathways—TGFBR1—thoracic aortic aneurysm	0.00012	0.000145	CbGpPWpGaD
Nilotinib—MAPK11—Signaling Pathways—TGFBR2—thoracic aortic aneurysm	0.000119	0.000144	CbGpPWpGaD
Nilotinib—BRAF—Signaling Pathways—TGFBR2—thoracic aortic aneurysm	0.000118	0.000143	CbGpPWpGaD
Nilotinib—MAPK14—Developmental Biology—MMP9—thoracic aortic aneurysm	0.000116	0.000141	CbGpPWpGaD
Nilotinib—KIT—Signaling Pathways—ADAM10—thoracic aortic aneurysm	0.000116	0.000141	CbGpPWpGaD
Nilotinib—PDGFRB—Disease—SMAD3—thoracic aortic aneurysm	0.000115	0.00014	CbGpPWpGaD
Nilotinib—MAPK14—Gene Expression—SMAD3—thoracic aortic aneurysm	0.000115	0.00014	CbGpPWpGaD
Nilotinib—LCK—Disease—ADAM10—thoracic aortic aneurysm	0.000113	0.000138	CbGpPWpGaD
Nilotinib—PDGFRA—Signaling Pathways—ADAM10—thoracic aortic aneurysm	0.00011	0.000133	CbGpPWpGaD
Nilotinib—KIT—Signaling Pathways—TGFBR2—thoracic aortic aneurysm	0.000107	0.00013	CbGpPWpGaD
Nilotinib—MAPK11—Signaling Pathways—SMAD3—thoracic aortic aneurysm	0.000105	0.000128	CbGpPWpGaD
Nilotinib—LCK—Disease—TGFBR2—thoracic aortic aneurysm	0.000105	0.000127	CbGpPWpGaD
Nilotinib—BRAF—Signaling Pathways—SMAD3—thoracic aortic aneurysm	0.000104	0.000127	CbGpPWpGaD
Nilotinib—LCK—Signaling Pathways—ADAM17—thoracic aortic aneurysm	0.000103	0.000126	CbGpPWpGaD
Nilotinib—LCK—Signaling Pathways—TGFBR1—thoracic aortic aneurysm	0.000103	0.000126	CbGpPWpGaD
Nilotinib—PDGFRA—Signaling Pathways—TGFBR2—thoracic aortic aneurysm	0.000101	0.000123	CbGpPWpGaD
Nilotinib—PDGFRB—Signaling Pathways—ADAM10—thoracic aortic aneurysm	9.88e-05	0.00012	CbGpPWpGaD
Nilotinib—LYN—Signaling Pathways—ADAM10—thoracic aortic aneurysm	9.67e-05	0.000117	CbGpPWpGaD
Nilotinib—KIT—Signaling Pathways—SMAD3—thoracic aortic aneurysm	9.48e-05	0.000115	CbGpPWpGaD
Nilotinib—LCK—Disease—SMAD3—thoracic aortic aneurysm	9.27e-05	0.000113	CbGpPWpGaD
Nilotinib—MAPK14—Signaling Pathways—ADAM10—thoracic aortic aneurysm	9.17e-05	0.000111	CbGpPWpGaD
Nilotinib—PDGFRB—Signaling Pathways—TGFBR2—thoracic aortic aneurysm	9.14e-05	0.000111	CbGpPWpGaD
Nilotinib—PDGFRA—Signaling Pathways—SMAD3—thoracic aortic aneurysm	8.97e-05	0.000109	CbGpPWpGaD
Nilotinib—LYN—Signaling Pathways—TGFBR2—thoracic aortic aneurysm	8.95e-05	0.000109	CbGpPWpGaD
Nilotinib—MAPK14—Signaling Pathways—TGFBR2—thoracic aortic aneurysm	8.48e-05	0.000103	CbGpPWpGaD
Nilotinib—PDGFRB—Signaling Pathways—SMAD3—thoracic aortic aneurysm	8.09e-05	9.82e-05	CbGpPWpGaD
Nilotinib—LCK—Signaling Pathways—ADAM10—thoracic aortic aneurysm	7.93e-05	9.63e-05	CbGpPWpGaD
Nilotinib—LYN—Signaling Pathways—SMAD3—thoracic aortic aneurysm	7.92e-05	9.62e-05	CbGpPWpGaD
Nilotinib—MAPK14—Signaling Pathways—SMAD3—thoracic aortic aneurysm	7.5e-05	9.12e-05	CbGpPWpGaD
Nilotinib—LCK—Signaling Pathways—TGFBR2—thoracic aortic aneurysm	7.33e-05	8.91e-05	CbGpPWpGaD
Nilotinib—MAPK8—Signaling Pathways—MMP9—thoracic aortic aneurysm	6.78e-05	8.24e-05	CbGpPWpGaD
Nilotinib—LCK—Signaling Pathways—SMAD3—thoracic aortic aneurysm	6.49e-05	7.88e-05	CbGpPWpGaD
Nilotinib—MAP2K5—Signaling Pathways—MMP9—thoracic aortic aneurysm	6.45e-05	7.83e-05	CbGpPWpGaD
Nilotinib—MAPK11—Signaling Pathways—MMP9—thoracic aortic aneurysm	5.4e-05	6.56e-05	CbGpPWpGaD
Nilotinib—BRAF—Signaling Pathways—MMP9—thoracic aortic aneurysm	5.35e-05	6.5e-05	CbGpPWpGaD
Nilotinib—KIT—Signaling Pathways—MMP9—thoracic aortic aneurysm	4.87e-05	5.92e-05	CbGpPWpGaD
Nilotinib—PDGFRA—Signaling Pathways—MMP9—thoracic aortic aneurysm	4.61e-05	5.6e-05	CbGpPWpGaD
Nilotinib—PDGFRB—Signaling Pathways—MMP9—thoracic aortic aneurysm	4.15e-05	5.05e-05	CbGpPWpGaD
Nilotinib—LYN—Signaling Pathways—MMP9—thoracic aortic aneurysm	4.07e-05	4.94e-05	CbGpPWpGaD
Nilotinib—MAPK14—Signaling Pathways—MMP9—thoracic aortic aneurysm	3.86e-05	4.68e-05	CbGpPWpGaD
Nilotinib—LCK—Signaling Pathways—MMP9—thoracic aortic aneurysm	3.33e-05	4.05e-05	CbGpPWpGaD
